59651-523 : Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 59651-523
Labeler: Aurobindo Pharma Limited
Product Type: Human Prescription Drug
Drug Name: Fosaprepitant Dimeglumine
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA210625
Rev. Date: 


NDC Package Codes:

  • 59651-523-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (59651‑523‑01) > 5 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Fosaprepitant Dimeglumine

Dosage Strength:

  • 150 mg/5mL

Pharmaceutical Classes:

  • Neurokinin 1 Antagonists [MoA]
  • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]

Related Products:

Based on records with the same trade name.
  • 0143-9384 Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9428 Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0781-3484 Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
  • 55150-299 Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Auromedics Pharma LLC
  • 67184-0540 Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Qilu Pharmaceutical Co., Ltd.
  • 82238-018 Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Eugia Pharma Specialities Limited

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 59651-523 QR Code

< Prev: 59651-516Next: 59651-524 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.